A cross-sectional study of people with epilepsy and Neurocysticercosis in Tanzania: Clinical characteristics and diagnostic approaches

PLoS Neglected Tropical Diseases

Volumn 5, Issue 6, 2011, Pages

  Blocher, Joachim ^a,b,c   Schmutzhard, Erich ^a   Wilkins, Patricia P ^d   Gupton, Paige N ^d   Schaffert, Matthias ^a,b   Auer, Herbert ^e   Gotwald, Thaddaeus ^a   Matuja, William ^f   Winkler, Andrea S ^b,g  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b HAYDOM LUTHERAN HOSPITAL   (Tanzania)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f MUHIMBILI NATIONAL HOSPITAL   (Tanzania)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; BRAIN CALCIFICATION; BRAIN DAMAGE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; EPILEPSY; ETHNICITY; FEMALE; FOLLOW UP; FOOD CONTAMINATION; FOOD INTAKE; HUMAN; IMMUNOBLOTTING; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NEUROIMAGING; RISK ASSESSMENT; RISK FACTOR; SANITATION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TANZANIA; ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; FEEDING BEHAVIOR; HEAD; INFANT; MIDDLE AGED; PATIENT COMPLIANCE; PRESCHOOL CHILD; RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EPILEPSY; FEEDING BEHAVIOR; FEMALE; FOLLOW-UP STUDIES; HEAD; HUMANS; INFANT; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEUROCYSTICERCOSIS; RISK FACTORS; TANZANIA; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79959841122     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001185     Document Type: Article

References (44)

1. Preux PM, Druet-Cabanac M, (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4: 21-31.
2. Meyer A, Dua T, Ma J, Saxena S, Birbeck G, (2010) Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 88: 260-266.
3. Dumas M, Preux PM, (2008) [Epilepsy in tropical areas]. Bull Acad Natl Med 192: 949-960.
4. Winkler AS, Kerschbaumsteiner K, Stelzhammer B, Meindl M, Kaaya J, et al. (2009) Prevalence, incidence, and clinical characteristics of epilepsy-a community-based door-to-door study in northern Tanzania. Epilepsia 50: 2310-2313.
5. De Bittencourt PR, Adamolekum B, Bharucha N, Carpio A, Cossío OH, et al. (1996) Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy. Epilepsia 37: 1128-1137.
6. Montano SM, Villaran MV, Ylquimiche L, Figueroa JJ, Rodriguez S, et al. (2005) Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65: 229-233.
7. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J, (2006) Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67: 2135-2139.
8. Medina MT, Durón RM, Martínez L, Osorio JR, Estrada AL, et al. (2005) Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salamá Study. Epilepsia 46: 124-131.
9. Quet F, Guerchet M, Pion SDS, Ngoungou EB, Nicoletti A, et al. (2010) Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 51: 830-837.
10. Ndimubanzi PC, Carabin H, Budke CM, Nguyen H, Qian Y, et al. (2010) A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl Trop Dis 4: e870.
11. Winkler AS, Willingham AL, Sikasunge CS, Schmutzhard E, (2009) Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr 121 (Suppl 3): 3-12.
12. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, et al. (2003) The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Trop 87: 13-23.
13. Carabin H, Krecek RC, Cowan LD, Michael L, Foyaca-Sibat H, et al. (2006) Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Trop Med Int Health 11: 906-916.
14. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2008) Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 102: 1032-1038.
15. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, et al. (2009) Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 50: 987-993.
16. Haydom Lutheran Hospital (2008) Haydom Lutheran Hospital Annual report 2008. Haydom Lutheran Hospital Available at: http://www.haydom.no/facts_and_map.aspx. Accessed March 10th, 2011.
17. Schaffert M, (2005) A clinic for people with epilepsy in rural Tanzania: patientś characteristics, a classification system, pattern of injuries and a 25-month follow up. Medical Thesis, Medical University Innsbruck.
18. Senanayake N, Román GC, (1993) Epidemiology of epilepsy in developing countries. Bull World Health Organ 71: 247-258.
19. Winkler AS, Schaffert M, Schmutzhard E, (2007) Epilepsy in resource poor countries-suggestion of an adjusted classification. Epilepsia 48: 1029-1030.
20. ILAE (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 22: 489-501.
21. Del Brutto OH, (2005) Neurocysticercosis. Semin Neurol 25: 243-251.
22. Del Brutto OH, Rajshekhar V, White AC, Tsang VC, Nash TE, et al. (2001) Proposed diagnostic criteria for neurocysticercosis. Neurology 57: 177-183.
23. Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A, et al. (2004) Calcific neurocysticercosis and epileptogenesis. Neurology 62: 1934-1938.
24. Nash TE, Singh G, White AC, Rajshekhar V, Loeb JA, et al. (2006) Treatment of neurocysticercosis: current status and future research needs. Neurology 67: 1120-1127.
25. Simac C, Michel P, Andriantsimahavandy A, Esterre P, Michault A, (1994) [Value of immunodiagnosis by ELISA and Western blotting for the diagnostic and therapeutic management of neurocysticercosis]. Arch Inst Pasteur Madagascar 61: 21-27.
26. Simac C, Michel P, Andriantsimahavandy A, Esterre P, Michault A, (1995) Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis. Parasitol Res 81: 132-136.
27. Michault A, Rivière B, Fressy P, Laporte JP, Bertil G, et al. (1990) [Contribution of enzyme-linked immuno-electrotransfer blot assay for the diagnosis of human neurocysticercosis]. Pathol Biol 38: 119-125.
28. Tsang VC, Brand JA, Boyer AE, (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159: 50-59.
29. Singhvi JP, Sawhney IM, Lal V, Pathak A, Prabhakar S, (2000) Profile of intractable epilepsy in a tertiary referral center. Neurol India 48: 351-356.
30. Serpa JA, Yancey LS, White AC, (2006) Advances in the diagnosis and management of neurocysticercosis. Expert Rev Anti Infect Ther 4: 1051-1061.
31. Rigatti M, Trevisol-Bittencourt PC, (1999) [Causes of late-onset epilepsy in an epilepsy clinic of Santa Catarina-Southern Brazil]. Arq Neuropsiquiatr 57: 787-792.
32. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, (1990) Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 150: 325-327.
33. Del Brutto OH, Santibáñez R, Idrovo L, Rodrìguez S, Díaz-Calderón E, et al. (2005) Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46: 583-587.
34. Nicoletti A, Bartoloni A, Sofia V, Bartalesi F, Chavez JR, et al. (2005) Epilepsy and neurocysticercosis in rural Bolivia: a population-based survey. Epilepsia 46: 1127-1132.
35. Dent W, Helbok R, Matuja WBP, Scheunemann S, Schmutzhard E, (2005) Prevalence of active epilepsy in a rural area in South Tanzania: a door-to-door survey. Epilepsia 46: 1963-1969.
36. Mac TL, Tran D, Quet F, Odermatt P, Preux PM, et al. (2007) Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 6: 533-543.
37. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, et al. (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42: 389-392.
38. Lescano AG, Garcia HH, Gilman RH, Gavidia CM, Tsang VCW, et al. (2009) Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis 3: e371.
39. Ngowi HA, Kassuku AA, Maeda GEM, Boa ME, Carabin H, et al. (2004) Risk factors for the prevalence of porcine cysticercosis in Mbulu District, Tanzania. Vet Parasitol 120: 275-283.
40. Wilkins PP, Wilson M, Allan JC, Tsang VCW, (2002) Taenia solium Cysticercosis: Immunodiagnosis of Neurocysticercosis and Taeniasis. In: Singh G, Prabhakar S (2002) Taenia solium cysticercosis. CAB International pp. 329-341.
41. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, et al. (1991) Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 164: 1007-1009.
42. Ong S, Talan DA, Moran GJ, Mower W, Newdow M, et al. (2002) Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerging Infect Dis 8: 608-613.
43. Kojic EM, White AC, (2003) A positive enzyme-linked immunoelectrotransfer blot assay result for a patient without evidence of cysticercosis. Clin Infect Dis 36: e7-9.
44. Proaño-Narvaez JV, Meza-Lucas A, Mata-Ruiz O, García-Jerónimo RC, Correa D, (2002) Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. J Clin Microbiol 40: 2115-2118.